Advertisement
Screener

IDEXX LABORATORIES INC /DE (IDXX) Increase (Decrease) in Accounts Payable, Trade

2.8 / 5 stars · 68/120 Roast Me

IDEXX LABORATORIES INC /DE Increase (Decrease) in Accounts Payable, Trade

IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Accounts Payable, Trade of -$557.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2024-02-22

  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for the quarter ending 2023-12-31 was $6.24M, a 15.61% decline year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for the quarter ending 2023-09-30 was -$2.64M, a 194.26% decline year-over-year.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for the quarter ending 2023-06-30 was -$7.48M.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for the quarter ending 2023-03-31 was $3.33M.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for fiscal 2023 was -$557.00K, a 116.07% decline from fiscal 2022.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for fiscal 2022 was $3.47M, a 69.14% decline from fiscal 2021.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for fiscal 2021 was $11.23M, a 1045.06% increase from fiscal 2020.
  • IDEXX LABORATORIES INC /DE increase (decrease) in accounts payable, trade for fiscal 2020 was $981.00K, a 49.87% decline from fiscal 2019.
Period endIncrease (Decrease) in Accounts Payable, Trade 3 monthIncrease (Decrease) in Accounts Payable, Trade 3 month as first filedIncrease (Decrease) in Accounts Payable, Trade 6 monthIncrease (Decrease) in Accounts Payable, Trade 6 month as first filedIncrease (Decrease) in Accounts Payable, Trade 9 monthIncrease (Decrease) in Accounts Payable, Trade 9 month as first filedIncrease (Decrease) in Accounts Payable, Trade 12 monthIncrease (Decrease) in Accounts Payable, Trade 12 month as first filed
2023-12-31$6.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$3.60M
derived: sum of 2 quarters · filed 2024-02-22
-$3.88M
derived: sum of 3 quarters · filed 2024-02-22
-$557.00K
10-K · filed 2024-02-22
2023-09-30-$2.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$10.13M
derived: sum of 2 quarters · filed 2023-11-01
-$6.80M
10-Q · filed 2023-11-01
$598.00K
derived: sum of 4 quarters · filed 2024-02-22
2023-06-30-$7.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$4.16M
10-Q · filed 2023-08-01
$3.24M
derived: sum of 3 quarters · filed 2024-02-22
$6.05M
derived: sum of 4 quarters · filed 2024-02-22
2023-03-31$3.33M
10-Q · filed 2023-05-02
$10.72M
derived: sum of 2 quarters · filed 2024-02-22
$13.53M
derived: sum of 3 quarters · filed 2024-02-22
$10.81M
derived: sum of 4 quarters · filed 2024-02-22
2022-12-31$7.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$10.20M
derived: sum of 2 quarters · filed 2024-02-22
$7.48M
derived: sum of 3 quarters · filed 2024-02-22
$3.47M
10-K · filed 2024-02-22
2022-09-30$2.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$86.00K
derived: sum of 2 quarters · filed 2023-11-01
-$3.93M
10-Q · filed 2023-11-01
$6.67M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30-$2.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$6.74M
10-Q · filed 2023-08-01
$3.86M
derived: sum of 3 quarters · filed 2024-02-22
$686.00K
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$4.02M
10-Q · filed 2023-05-02
$6.58M
derived: sum of 2 quarters · filed 2024-02-22
$3.40M
derived: sum of 3 quarters · filed 2024-02-22
$4.76M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$10.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$7.42M
derived: sum of 2 quarters · filed 2024-02-22
$8.77M
derived: sum of 3 quarters · filed 2024-02-22
$11.23M
10-K · filed 2024-02-22
2021-09-30-$3.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
-$1.82M
derived: sum of 2 quarters · filed 2022-11-01
$637.00K
10-Q · filed 2022-11-01
$1.11M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$1.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$3.81M
10-Q · filed 2022-08-02
$4.28M
derived: sum of 3 quarters · filed 2023-02-16
$11.52M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$2.46M
10-Q · filed 2022-05-04
$2.93M
derived: sum of 2 quarters · filed 2023-02-16
$10.17M
derived: sum of 3 quarters · filed 2023-02-16
$5.20M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$469.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$7.71M
derived: sum of 2 quarters · filed 2023-02-16
$2.74M
derived: sum of 3 quarters · filed 2023-02-16
$981.00K
10-K · filed 2023-02-16
2020-09-30$7.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$2.27M
derived: sum of 2 quarters · filed 2021-11-02
$512.00K
10-Q · filed 2021-11-02
$1.29M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30-$4.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$6.73M
10-Q · filed 2021-07-30
-$5.95M
derived: sum of 3 quarters · filed 2022-02-16
-$742.00K
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31-$1.75M
10-Q · filed 2021-05-04
-$979.00K
derived: sum of 2 quarters · filed 2022-02-16
$4.23M
derived: sum of 3 quarters · filed 2022-02-16
-$497.00K
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$776.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$5.99M
derived: sum of 2 quarters · filed 2022-02-16
$1.26M
derived: sum of 3 quarters · filed 2022-02-16
$1.96M
10-K · filed 2022-02-16
2019-09-30$5.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$482.00K
derived: sum of 2 quarters · filed 2020-10-29
$1.18M
10-Q · filed 2020-10-29
$2.35M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30-$4.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$4.03M
10-Q · filed 2020-07-31
-$2.86M
derived: sum of 3 quarters · filed 2021-02-12
-$4.20M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$699.00K
10-Q · filed 2020-04-30
$1.87M
derived: sum of 2 quarters · filed 2021-02-12
$530.00K
derived: sum of 3 quarters · filed 2021-02-12
$2.47M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$169.00K
derived: sum of 2 quarters · filed 2021-02-12
$1.77M
derived: sum of 3 quarters · filed 2021-02-12
-$166.00K
10-K · filed 2021-02-12
2018-09-30-$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$603.00K
derived: sum of 2 quarters · filed 2019-10-31
-$1.34M
10-Q · filed 2019-10-31
$3.60M
derived: sum of 4 quarters · filed 2020-02-14
2018-06-30$1.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$3.00K
10-Q · filed 2019-08-01
$4.93M
derived: sum of 3 quarters · filed 2020-02-14
-$28.00K
derived: sum of 4 quarters · filed 2020-02-14
2018-03-31-$1.94M
10-Q · filed 2019-05-01
$2.99M
derived: sum of 2 quarters · filed 2020-02-14
-$1.97M
derived: sum of 3 quarters · filed 2020-02-14
$3.14M
derived: sum of 4 quarters · filed 2020-02-14
2017-12-31$4.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14
-$31.00K
derived: sum of 2 quarters · filed 2020-02-14
$5.08M
derived: sum of 3 quarters · filed 2020-02-14
$1.39M
10-K · filed 2020-02-14
2017-09-30-$4.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$147.00K
derived: sum of 2 quarters · filed 2018-11-01
-$3.54M
10-Q · filed 2018-11-01
$1.07M
derived: sum of 4 quarters · filed 2019-02-15
2017-06-30$5.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$1.42M
10-Q · filed 2018-08-01
$6.04M
derived: sum of 3 quarters · filed 2019-02-15
$3.44M
derived: sum of 4 quarters · filed 2019-02-15
2017-03-31-$3.69M
10-Q · filed 2018-05-04
$926.00K
derived: sum of 2 quarters · filed 2019-02-15
-$1.67M
derived: sum of 3 quarters · filed 2019-02-15
$231.00K
derived: sum of 4 quarters · filed 2019-02-15
2016-12-31$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15
$2.02M
derived: sum of 2 quarters · filed 2019-02-15
$3.92M
derived: sum of 3 quarters · filed 2019-02-15
$2.12M
10-K · filed 2019-02-15
2016-09-30-$2.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$695.00K
derived: sum of 2 quarters · filed 2017-10-31
-$2.50M
10-Q · filed 2017-10-31
-$2.12M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$99.00K
10-Q · filed 2017-08-01
$472.00K
derived: sum of 3 quarters · filed 2018-02-16
$623.00K
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31-$1.80M
10-Q · filed 2017-04-28
-$1.43M
derived: sum of 2 quarters · filed 2018-02-16
-$1.28M
derived: sum of 3 quarters · filed 2018-02-16
$63.00K
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$373.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$524.00K
derived: sum of 2 quarters · filed 2018-02-16
$1.86M
derived: sum of 3 quarters · filed 2018-02-16
-$2.47M
10-K · filed 2018-02-16
2015-09-30$151.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
$1.49M
derived: sum of 2 quarters · filed 2016-11-01
-$2.84M
10-Q · filed 2016-11-01
-$3.01M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$1.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02
-$2.99M
10-Q · filed 2016-08-02
-$3.17M
derived: sum of 3 quarters · filed 2017-02-17
$3.37M
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31-$4.33M
10-Q · filed 2016-04-29
-$4.50M
derived: sum of 2 quarters · filed 2017-02-17
$2.03M
derived: sum of 3 quarters · filed 2017-02-17
$514.00K
derived: sum of 4 quarters · filed 2017-02-17
2014-12-31-$173.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
$6.37M
derived: sum of 2 quarters · filed 2017-02-17
$4.85M
derived: sum of 3 quarters · filed 2017-02-17
$6.70M
10-K · filed 2017-02-17
2014-09-30$6.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28
$5.02M
derived: sum of 2 quarters · filed 2015-10-28
$6.88M
10-Q · filed 2015-10-28
-$1.48M
derived: sum of 4 quarters · filed 2016-02-17
2014-06-30-$1.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$337.00K
10-Q · filed 2015-07-30
-$8.02M
derived: sum of 3 quarters · filed 2016-02-17
-$10.53M
derived: sum of 4 quarters · filed 2016-02-17
2014-03-31$1.86M
10-Q · filed 2015-04-28
-$6.50M
derived: sum of 2 quarters · filed 2016-02-17
-$9.01M
derived: sum of 3 quarters · filed 2016-02-17
-$8.11M
derived: sum of 4 quarters · filed 2016-02-17
2013-12-31-$8.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17
-$10.87M
derived: sum of 2 quarters · filed 2016-02-17
-$9.97M
derived: sum of 3 quarters · filed 2016-02-17
-$4.40M
10-K · filed 2016-02-17
2013-09-30-$2.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24
-$1.61M
derived: sum of 2 quarters · filed 2014-10-24
$3.96M
10-Q · filed 2014-10-24
$2.18M
10-Q · filed 2013-10-22
$5.95M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-30$899.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25
$6.47M
10-Q · filed 2014-07-25
$2.55M
10-Q · filed 2013-07-23
$8.46M
derived: sum of 3 quarters · filed 2015-02-17
$10.33M
derived: sum of 4 quarters · filed 2015-02-17
2013-03-31$5.57M
10-Q · filed 2014-04-25
$3.65M
10-Q · filed 2013-04-23
$7.56M
derived: sum of 2 quarters · filed 2015-02-17
$9.43M
derived: sum of 3 quarters · filed 2015-02-17
-$1.32M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
$3.86M
derived: sum of 2 quarters · filed 2015-02-17
-$6.89M
derived: sum of 3 quarters · filed 2015-02-17
-$2.90M
10-K · filed 2015-02-17
-$1.30M
10-K · filed 2013-02-19
2012-09-30$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22
-$8.88M
derived: sum of 2 quarters · filed 2013-10-22
-$4.89M
10-Q · filed 2013-10-22
-$183.00K
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30-$10.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23
-$6.76M
10-Q · filed 2013-07-23
-$2.05M
derived: sum of 3 quarters · filed 2014-02-18
-$746.00K
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$3.99M
10-Q · filed 2013-04-23
$8.70M
derived: sum of 2 quarters · filed 2014-02-18
$10.00M
derived: sum of 3 quarters · filed 2014-02-18
$16.46M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31$4.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$6.01M
derived: sum of 2 quarters · filed 2014-02-18
$12.47M
derived: sum of 3 quarters · filed 2014-02-18
$13.02M
10-K · filed 2014-02-18
$13.88M
10-K · filed 2012-02-17
2011-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19
$7.76M
derived: sum of 2 quarters · filed 2012-10-19
$8.30M
10-Q · filed 2012-10-19
$5.68M
derived: sum of 4 quarters · filed 2013-02-19
2011-06-30$6.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20
$7.00M
10-Q · filed 2012-07-20
$4.38M
derived: sum of 3 quarters · filed 2013-02-19
$6.18M
derived: sum of 4 quarters · filed 2013-02-19
2011-03-31$548.00K
10-Q · filed 2012-04-20
-$2.08M
derived: sum of 2 quarters · filed 2013-02-19
-$278.00K
derived: sum of 3 quarters · filed 2013-02-19
-$1.05M
derived: sum of 4 quarters · filed 2013-02-19
2010-12-31-$2.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19
-$826.00K
derived: sum of 2 quarters · filed 2013-02-19
-$1.60M
derived: sum of 3 quarters · filed 2013-02-19
$3.48M
10-K · filed 2013-02-19
2010-09-30$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21
$1.03M
derived: sum of 2 quarters · filed 2011-10-21
$6.11M
10-Q · filed 2011-10-21
2010-06-30-$773.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22
$4.31M
10-Q · filed 2011-07-22
2010-03-31$5.08M
10-Q · filed 2011-04-21
2009-12-31-$9.16M
10-K · filed 2012-02-17
2008-12-31-$4.33M
10-K · filed 2011-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lantheus Holdings, Inc. (LNTH)United States$6.510B26.31
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10